Gen XY Updates from GlobeNewswire
2024-05-09T01:15:00Z
ALISO VIEJO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, announced...
2024-05-09T01:09:28Z
Starting today, Frontier Customers will have access to more than 40 destinations in Mexico through Volaris Partnership
2024-05-09T00:53:29Z
Announces Plan for $20 million in Aggregate New Financing to Support Daily Operations, Restructuring, Strategic Initiatives, and Advocacy
2024-05-09T00:00:12Z
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches based on...
2024-05-08T21:47:25Z
CHARLOTTESVILLE, Va., May 08, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the...
2024-05-08T21:35:00Z
Company acquired all assets for the synergistic CNSide cerebrospinal fluid diagnostic portfolio
2024-05-08T21:15:43Z
Havila Pollux has been docked in Bergen since May 2nd for planned warranty work, after an electro motor supplying power to the propulsion system had to be replaced. In recent...
2024-05-08T20:45:41Z
MIAMI, May 08, 2024 (GLOBE NEWSWIRE) -- ONEflight International, a leader in the Private Jet Travel, proudly welcomed its members to the highly anticipated Formula 1 Miami Grand Prix, treating...
2024-05-08T20:42:24Z
LAS VEGAS, May 08, 2024 (GLOBE NEWSWIRE) -- Golden Matrix Group Inc. (NASDAQ: GMGI), a leading B2B and B2C gaming technology company utilizing proprietary technology and operating globally across 17...
2024-05-08T20:30:54Z
NEW YORK and WALTHAM, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics...
2024-05-08T20:30:00Z
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will participate in the following upcoming investor conferences:
2024-05-08T20:30:00Z
DUBLIN, IRELAND , May 08, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 fourth quarter ended March 31,...
2024-05-08T20:30:00Z
JERSEY CITY, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today reported financial...
2024-05-08T20:18:34Z
Conference Call to Begin Today at 5:00 p.m. (ET)
2024-05-08T20:16:20Z
Achieved Total Q1 2024 Revenues of $98.5 Million, a 15.4% YoY Increase, Underscored by Exceptional Execution and Continued Demand for Commercial Products
2024-05-08T20:15:38Z
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific...
2024-05-08T20:15:00Z
CHARLOTTE, N.C., May 08, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.
2024-05-08T20:15:00Z
ALPHARETTA, Ga., May 08, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space...
2024-05-08T20:15:00Z
GARDNER, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense...
2024-05-08T20:10:00Z
- Company announces positive initial Phase 1a dose escalation data for monotherapy CX-904 (EGFRxCD3 T-cell engager) in solid tumors -
2024-05-08T20:10:00Z
- CX-904 demonstrated a favorable safety profile with no cytokine release syndrome (CRS) of any grade observed in step-dosing cohorts and no grade >1 CRS observed overall -
2024-05-08T20:10:00Z
- Enrollment target exceeded in aplitabart randomized colorectal cancer clinical trial -
2024-05-08T20:10:00Z
ZUG, Switzerland, May 08, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks,...
2024-05-08T20:10:00Z
ZUG, Switzerland, May 08, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company purposefully driven to save sight and improve...
2024-05-08T20:10:00Z
ZUG, Switzerland, May 08, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company purposefully driven to save sight and improve...
2024-05-08T20:08:54Z
Steve Griffin Appointed Chief Financial Officer, Effective June 3, 2024
2024-05-08T20:06:26Z
Announced FDA clearance of IND application for a Phase 1 clinical trial of CTIM-76
2024-05-08T20:05:53Z
FREMONT, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the first...
2024-05-08T20:05:50Z
ROCKVILLE, Md., May 08, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS)...
2024-05-08T20:05:47Z
Demonstrated the power of the Proteograph Product Suite with a growing number of customer presentations and publications
2024-05-08T20:05:17Z
Revenue up 7% on growing demand and favorable order timing; On-track for 2024 revenue guidance
2024-05-08T20:05:14Z
TAMPA, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) today announced that it intends to offer, subject to market and other conditions, $250.0 million aggregate principal...
2024-05-08T20:05:00Z
FOSTER CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to...
2024-05-08T20:05:00Z
Advancing DT-216P2, New Drug Product for Friedreich Ataxia (FA), Toward Clinical Trials
2024-05-08T20:05:00Z
Generated $24.7 million in net product sales of XDEMVY®, an 89% increase over Q4 2023, and delivered approximately 26,000 bottles of XDEMVY to patients
2024-05-08T20:05:00Z
LOS ANGELES, May 08, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 375 owned...
2024-05-08T20:05:00Z
SOUTH SAN FRANCISCO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today reported financial results and...
2024-05-08T20:05:00Z
- Revenues Increased 39.6% to $69.9 Million in the First Quarter of 2024
2024-05-08T20:05:00Z
-- Revenue increased to $18.1 million in Q1 2024, a 25% increase over Q1 2023 ---- Extended the maturity date of the Company’s term loan by one year to September...
2024-05-08T20:05:00Z
SZN-043 Phase 1a clinical trial results to be presented at the 2024 European Association for the Study of the Liver (EASL) in Milan
2024-05-08T20:05:00Z
Record first quarter 2024 net sales of $5.4 million, an increase of 96% over first quarter 2023Company to host a conference call and webcast today, May 8, 2024 at 4:30 PM EST
2024-05-08T20:05:00Z
FOSTER CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced...
2024-05-08T20:05:00Z
Conference call begins at 4:30 p.m. Eastern time today
2024-05-08T20:05:00Z
ALISO VIEJO, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., (Nasdaq: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, announced...
2024-05-08T20:05:00Z
Goal to treat 40-60 patients in 2024 in four trials across seven indications in oncology, B-cell mediated autoimmune diseases, and type 1 diabetes
2024-05-08T20:05:00Z
First quarter system-wide sales growth of 1.9% and AWS of $24,250
2024-05-08T20:05:00Z
Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation
2024-05-08T20:05:00Z
-- VAX-31 Adult Phase 1/2 Study Enrollment Completed; Topline Safety, Tolerability and Immunogenicity Data Expected in Third Quarter of 2024 ---- Following VAX-31 Adult Phase 1/2 Study Readout, Vaxcyte to...
2024-05-08T20:05:00Z
Initial Data from Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia to be Presented, Along with Initial Findings from Phase 1b/2a ACTH-Dependent Cushing’s Syndrome Trial
2024-05-08T20:05:00Z
MOUNTAIN VIEW, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment...
